Q4 2025 · 13F-HR
Integral Health Asset Management, LLCholdings as filed
Filed 2026-02-17 · accession 0001172661-26-000915
$2.01B
Reported value
86
Positions
2025-12-31
Period end
The Brief · Integral Health Asset Management, LLC · Q4 2025
AI · grounded in 13F
Integral Health Asset Management, LLC initiated a new position in DXCM valued at $33.19M. The fund closed its positions in NAMS, reducing exposure by $28.44M, and NVO, reducing exposure by $22.20M. Other notable activity includes increasing share counts in MDT by 350% and ISRG by 340%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 457669307 | INSM | INSMED INC | $217.6M | 10.8% | 1,250,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $95.6M | 4.75% | 1,200,000 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $91.2M | 4.53% | 1,800,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $89.0M | 4.42% | 1,400,000 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $81.0M | 4.02% | 105,000 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $64.8M | 3.22% | 675,000 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $62.3M | 3.09% | 110,000 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $50.8M | 2.52% | 475,000 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE INC | $43.5M | 2.16% | 2,200,000 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $41.1M | 2.04% | 200,000 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $39.7M | 1.97% | 500,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $37.2M | 1.85% | 1,500,000 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $36.7M | 1.82% | 325,000 | Common | SOLE |
| 66987V109 | NVS | NOVARTIS AG | $34.5M | 1.71% | 250,000 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $33.2M | 1.65% | 500,000 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $32.2M | 1.60% | 350,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $31.8M | 1.58% | 500,000 | CALL | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $31.2M | 1.55% | 1,000,000 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $31.1M | 1.54% | 100,000 | Common | SOLE |
| 879369106 | TFX | TELEFLEX INCORPORATED | $30.5M | 1.51% | 250,000 | Common | SOLE |
| 10950A106 | BTSG | BRIGHTSPRING HEALTH SVCS INC | $28.1M | 1.39% | 750,000 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $27.7M | 1.38% | 325,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $27.2M | 1.35% | 750,000 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $26.7M | 1.33% | 650,000 | Common | SOLE |
| 216648501 | COO | COOPER COS INC | $26.6M | 1.32% | 325,000 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $26.3M | 1.31% | 250,000 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $23.9M | 1.18% | 60,000 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES INC | $23.1M | 1.15% | 130,000 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $21.5M | 1.07% | 900,000 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $21.5M | 1.07% | 20,000 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $21.5M | 1.07% | 225,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $21.3M | 1.06% | 150,000 | Common | SOLE |
| 53228F101 | LFST | LIFESTANCE HEALTH GROUP INC | $21.1M | 1.05% | 3,000,000 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC FORMERLY | $21.0M | 1.04% | 60,000 | Common | SOLE |
| 91678A107 | UPB | UPSTREAM BIO INC | $20.4M | 1.01% | 750,000 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $19.9M | 0.99% | 100,000 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $19.2M | 0.95% | 90,000 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $18.4M | 0.92% | 850,000 | Common | SOLE |
| 26622P107 | DOCS | DOXIMITY INC | $17.7M | 0.88% | 400,000 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $17.6M | 0.87% | 100,000 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $17.3M | 0.86% | 1,200,000 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $17.2M | 0.85% | 425,000 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $16.9M | 0.84% | 1,500,000 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $16.5M | 0.82% | 50,000 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $16.4M | 0.81% | 200,000 | Common | SOLE |
| 358029106 | FMS | FRESENIUS MEDICAL CARE AG | $15.5M | 0.77% | 650,000 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $15.2M | 0.76% | 550,000 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $15.0M | 0.75% | 325,000 | Common | SOLE |
| 750491102 | RDNT | RADNET INC | $14.3M | 0.71% | 200,000 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $13.2M | 0.66% | 300,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $13.0M | 0.65% | 200,000 | Common | SOLE |
| 74834L100 | DGX | QUEST DIAGNOSTICS INC | $13.0M | 0.65% | 75,000 | Common | SOLE |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $12.2M | 0.61% | 3,000,000 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $12.0M | 0.60% | 2,250,000 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $11.8M | 0.59% | 40,000 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $11.3M | 0.56% | 275,000 | Common | SOLE |
| 29415F104 | NVST | ENVISTA HOLDINGS CORPORATION | $10.9M | 0.54% | 500,000 | Common | SOLE |
| 29261A100 | EHC | ENCOMPASS HEALTH CORP | $10.6M | 0.53% | 100,000 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $9.8M | 0.49% | 1,200,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $9.1M | 0.45% | 250,000 | CALL | SOLE |
| 159864107 | CRL | CHARLES RIV LABS INTL INC | $9.0M | 0.45% | 45,000 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $8.0M | 0.40% | 80,000 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $6.9M | 0.34% | 75,000 | Common | SOLE |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $6.7M | 0.33% | 375,000 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $6.7M | 0.33% | 100,000 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $6.6M | 0.33% | 100,000 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $5.9M | 0.29% | 125,000 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $5.7M | 0.28% | 300,000 | Common | SOLE |
| 28414H103 | ELAN | ELANCO ANIMAL HEALTH INC | $5.7M | 0.28% | 250,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $5.0M | 0.25% | 200,000 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $4.7M | 0.23% | 2,000,000 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $4.7M | 0.23% | 350,000 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $4.2M | 0.21% | 200,000 | Common | SOLE |
| 578784100 | MAZE | MAZE THERAPEUTICS INC | $4.1M | 0.21% | 100,000 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT INC | $3.7M | 0.18% | 200,000 | Common | SOLE |
| 45719W205 | IKT | INHIBIKASE THERAPEUTICS INC | $3.6M | 0.18% | 1,750,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $3.5M | 0.17% | 100,000 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $3.5M | 0.17% | 50,000 | Common | SOLE |
| 82657M105 | SGHT | SIGHT SCIENCES INC | $3.4M | 0.17% | 425,000 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $3.1M | 0.15% | 1,000,000 | Common | SOLE |
| 687793109 | OSCR | OSCAR HEALTH INC | $2.9M | 0.14% | 200,000 | Common | SOLE |
| 50180M108 | LBRX | LB PHARMACEUTICALS INC | $2.2M | 0.11% | 100,000 | Common | SOLE |
| 30054Y107 | EVMN | EVOMMUNE INC | $2.1M | 0.11% | 125,000 | Common | SOLE |
| 88032L605 | TENX | TENAX THERAPEUTICS INC | $2.0M | 0.10% | 167,000 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $1.8M | 0.09% | 200,000 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $1.6M | 0.08% | 200,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.